Patients with end-stage kidney disease (ESKD) requiring kidney replacement therapy are
often treated in conventional dialysis centers at substantial cost and patient inconvenience …

Individualization of hemoglobin targets using EPO-stimulating agents and iron
supplementation may be considered in younger, healthier patients with kidney disease to …

Kidney failure is a rapidly growing global public health problem and fatal without dialysis or
transplantation. CKD is reported to affect> 10% of the general population worldwide, which …

Setting Up Home Dialysis Programs: Now and in the Future : Clinical Journal of the
American Society of Nephrology Setting Up Home Dialysis Programs: Now and in the …

Purpose To investigate current treatment practices for anemia in patients with chronic kidney
disease (CKD), issues surrounding current treatment practices, and the hypoxia-inducible …

Patients with progressive renal insufficiency are faced with a multitude of decisions and
choices during the continuum of their care. Those that choose to embark on the road to renal …

Expanding treatment modalities available to patients with kidney failure is now a priority in
the United States. On July 10, 2019, a presidential executive order launched the Advancing …

There is a resurgence in clinical adoption of home hemodialysis globally driven by several
demonstrated clinical and economic advantages. Yet, the overall adoption of home …

The 2019 Advancing American Kidney Health Initiative proposed to increase the number of
US patients with kidney failure treated at home, whether by peritoneal dialysis (PD) or home …

Patients with end‐stage kidney disease (ESKD) require dialysis or a kidney transplant for
survival and over 760 000 patients now benefit from these therapies in the United States …